Entity Common Stock, Shares Outstanding of BIOCEPT INC from 02 Mar 2014 to 08 Aug 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BIOCEPT INC quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 02 Mar 2014 to 08 Aug 2023.
  • BIOCEPT INC Entity Common Stock, Shares Outstanding for the quarter ending 08 Aug 2023 was 2,626,026, a 84% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

BIOCEPT INC Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2023 2,626,026 -14,296,842 -84% 08 Aug 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 17,777,185 +927,024 +5.5% 13 Apr 2023 10-K 17 Apr 2023 2022 FY
Q4 2022 17,058,770 17 Nov 2022 10-Q 21 Nov 2022 2022 Q3
Q3 2022 17,058,770 +216,524 +1.3% 10 Nov 2022 10-Q 10 Nov 2022 2022 Q2
Q2 2022 16,922,868 +2,199,910 +15% 16 May 2022 10-Q 23 May 2022 2022 Q1
Q1 2022 16,850,161 +3,447,793 +26% 18 Mar 2022 10-K 05 Apr 2022 2021 FY
Q3 2021 16,842,246 +3,445,498 +26% 08 Nov 2021 10-Q/A 15 Feb 2022 2021 Q3
Q2 2021 14,722,958 -119,211,356 -89% 12 Aug 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 13,402,368 -95,305,024 -88% 19 Mar 2021 10-K 31 Mar 2021 2020 FY
Q3 2020 13,396,748 -9,621,487 -42% 06 Nov 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 133,934,314 +110,916,079 +482% 07 Aug 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 108,707,392 +89,890,316 +478% 20 Mar 2020 10-K 27 Mar 2020 2019 FY
Q3 2019 23,018,235 +18,956,807 +467% 08 Nov 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 23,018,235 +20,744,457 +912% 10 Aug 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 18,817,076 -49,221,273 -72% 25 Mar 2019 10-K 29 Mar 2019 2018 FY
Q3 2018 4,061,428 -26,197,315 -87% 07 Nov 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 2,273,778 -27,979,965 -92% 10 Aug 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 68,038,349 +45,758,102 +205% 26 Mar 2018 10-K 28 Mar 2018 2017 FY
Q3 2017 30,258,743 +12,759,346 +73% 09 Nov 2017 10-Q 14 Nov 2017 2017 Q3
Q2 2017 30,253,743 +5,064,329 +20% 10 Aug 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 22,280,247 +2,596,845 +13% 24 Mar 2017 10-K 28 Mar 2017 2016 FY
Q3 2016 17,499,397 -1,307,506 -7% 04 Nov 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 25,189,414 +6,485,868 +35% 02 Aug 2016 10-Q 05 Aug 2016 2016 Q2
Q1 2016 19,683,402 +1,781,850 +10% 03 Mar 2016 10-K 10 Mar 2016 2015 FY
Q3 2015 18,806,903 +14,357,300 +323% 02 Nov 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 18,703,546 +14,253,943 +320% 05 Aug 2015 10-Q 11 Aug 2015 2015 Q2
Q1 2015 17,901,552 +1,935,500 +12% 06 May 2015 10-Q 13 May 2015 2015 Q1
Q3 2014 4,449,603 10 Nov 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 4,449,603 01 Aug 2014 10-Q 08 Aug 2014 2014 Q2
Q1 2014 15,966,052 02 Mar 2014 10-K 11 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.